Chemoinformaics analysis of 2-Ethoxy-1-methoxy-4-(1-propenyl)benzene
Molecular Weight | 192.258 | nRot | 4 |
Heavy Atom Molecular Weight | 176.13 | nRig | 7 |
Exact Molecular Weight | 192.115 | nRing | 1 |
Solubility: LogS | -3.348 | nHRing | 0 |
Solubility: LogP | 2.873 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 32.3127 |
nHD | 0 | BPOL | 19.5233 |
QED | 0.729 |
Synth | 1.818 |
Natural Product Likeliness | 0.055 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.117 |
Pgp-sub | 0.654 |
HIA | 0.003 |
CACO-2 | -4.334 |
MDCK | 0.000022 |
BBB | 0.59 |
PPB | 0.9524 |
VDSS | 2.152 |
FU | 0.0434526 |
CYP1A2-inh | 0.981 |
CYP1A2-sub | 0.946 |
CYP2c19-inh | 0.752 |
CYP2c19-sub | 0.828 |
CYP2c9-inh | 0.224 |
CYP2c9-sub | 0.117 |
CYP2d6-inh | 0.125 |
CYP2d6-sub | 0.602 |
CYP3a4-inh | 0.315 |
CYP3a4-sub | 0.62 |
CL | 10.339 |
T12 | 0.695 |
hERG | 0.036 |
Ames | 0.019 |
ROA | 0.007 |
SkinSen | 0.095 |
Carcinogencity | 0.553 |
EI | 0.89 |
Respiratory | 0.032 |
NR-Aromatase | 0.011 |
Antiviral | No |
Prediction | 0.654928 |